Li S C, Kihara H, Serizawa S, Li Y T, Fluharty A L, Mayes J S, Shapiro L J
J Biol Chem. 1985 Feb 10;260(3):1867-71.
Urine specimens from two sibs affected with cerebroside sulfatase activator deficiency were examined to ascertain whether the deficiency of the supplementary activator protein required for the enzymatic hydrolysis of cerebroside sulfate was also evident in urine. Material from chromatographic fractionations was examined for the activator activity to avoid ambiguities resulting from protein inhibition. There were substantial deficits in all chromatographic fractions corresponding to activator-containing fractions of control urines. Since patient urines contained elevated amounts of lactosylceramide, digalactosylceramide, and globotriaosylceramide and since similarities between activators for cerebroside sulfate and GM1 ganglioside hydrolyses had been noted previously, the chromatographic fractions were also examined for activators in other glycosphingolipid hydrolase systems. There was coincidence of activators for the GM1 ganglioside/beta-galactosidase and the globotriaosylceramide/alpha-galactosidase A reactions with the cerebroside sulfatase activator in control urine fractions, and the patients' urines were deficient in activator activities for the three reactions. Identity of the three activators was suggested and antiserum to purified GM1 ganglioside activator was used to test this possibility. There were depressed levels of cross-reacting material in fractions of patient urines by Ouchterlony double diffusion and in unfractionated urine by enzyme-linked immunosorbent assay. Purified activators for the cerebroside sulfate and GM1 ganglioside systems showed lines of identity with no spurring on Ouchterlony double diffusion, identical mobility on immunoelectrophoresis, and similar stimulatory activities toward hydrolysis of the three glycosphingolipid species by their respective enzymes. Finally, the three activator activities were retained by anti-GM1-activator IgG coupled to Sepharose 4B. The results suggest strongly that the same protein entity serves as activator for the enzymatic hydrolysis of cerebroside sulfate, GM1 ganglioside, and globotriaosylceramide.
对两名患有脑苷脂硫酸酯酶激活剂缺乏症的同胞的尿液样本进行了检查,以确定硫酸脑苷脂酶促水解所需的补充激活蛋白的缺乏在尿液中是否也很明显。对色谱分离物的材料进行了激活剂活性检测,以避免因蛋白质抑制导致的歧义。与对照尿液中含激活剂的组分相对应的所有色谱组分均存在大量缺陷。由于患者尿液中乳糖基神经酰胺、二半乳糖基神经酰胺和球三糖基神经酰胺的含量升高,且此前已注意到硫酸脑苷脂激活剂与GM1神经节苷脂水解激活剂之间的相似性,因此还对色谱组分进行了其他糖鞘脂水解酶系统中激活剂的检测。在对照尿液组分中,GM1神经节苷脂/β-半乳糖苷酶和球三糖基神经酰胺/α-半乳糖苷酶A反应的激活剂与硫酸脑苷脂酶激活剂一致,而患者尿液中这三种反应的激活剂活性均缺乏。有人提出这三种激活剂具有同一性,并使用针对纯化的GM1神经节苷脂激活剂的抗血清来检验这种可能性。通过双向免疫扩散法检测患者尿液组分中以及通过酶联免疫吸附测定法检测未分级尿液中交叉反应物质的水平均降低。硫酸脑苷脂和GM1神经节苷脂系统的纯化激活剂在双向免疫扩散中显示出同一性线条,无刺突现象,在免疫电泳中迁移率相同,并且对各自酶催化的三种糖鞘脂物质水解具有相似的刺激活性。最后,三种激活剂活性被偶联到琼脂糖4B上的抗GM1激活剂IgG保留。结果强烈表明,同一蛋白质实体作为硫酸脑苷脂、GM1神经节苷脂和球三糖基神经酰胺酶促水解的激活剂。